Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3863Neoplasms 2988Prostatic Neoplasms 1754Colorectal Neoplasms 1430Lung Neoplasms 1331Motor Activity 805Head and Neck Neoplasms 686Pancreatic Neoplasms 663Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Non-Small-Cell Lung 631Carcinoma, Hepatocellular 631Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 484Ovarian Neoplasms 441Anxiety Disorders 420Pain 419Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 374Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 340Melanoma 323Multiple Myeloma 322Lymphoma 306Depression 306Endometrial Neoplasms 290Liver Neoplasms 279

Interventions

Magnetic Resonance Spectroscopy 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Interventional × Cancer of Lymph Node × Clear all
NCT01815333 2020-10-19

Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging

M.D. Anderson Cancer Center

Phase NA Completed
10 enrolled 5 charts

Cancer of Lymph Node

Data powered by HemOnc (CC BY 4.0) Colophon âš¡